A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study

Update Il y a 4 ans
Reference: NCT00947856

Woman and Man

Extract

This is a multicenter, open-label study to evaluate the safety and efficacy of treatment with brentuximab vedotin (SGN-35) in patients who have previously participated in an brentuximab vedotin study.


Inclusion criteria

  • Disease, Hodgkin ,Lymphoma, Large-Cell, Anaplastic ,Lymphoma. Non-Hodgkin

Links